Neuronetics Stock Investor Sentiment
| STIM Stock | USD 0.96 0.01 1.05% |
About 52% of Neuronetics' investor base is interested to short. The analysis of overall sentiment of trading Neuronetics stock suggests that many investors are impartial at this time. Neuronetics' investing sentiment overview a quick insight into current market opportunities from investing in Neuronetics. Many technical investors use Neuronetics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Neuronetics |
Neuronetics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Neuronetics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Neuronetics that are available to investors today. That information is available publicly through Neuronetics media outlets and privately through word of mouth or via Neuronetics internal channels. However, regardless of the origin, that massive amount of Neuronetics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Neuronetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuronetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuronetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuronetics alpha.
Neuronetics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Muir Glenn P of 25000 shares of Neuronetics at 0.8 subject to Rule 16b-3 | 09/05/2024 |
2 | Acquisition by Cascella Robert of 100000 shares of Neuronetics at 0.75 subject to Rule 16b-3 | 09/12/2024 |
3 | Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings | 10/04/2024 |
4 | Disposition of 1541 shares by Macan William Andrew of Neuronetics at 0.82 subject to Rule 16b-3 | 10/08/2024 |
5 | Acquisition by Muir Glenn P of 25000 shares of Neuronetics at 1.0 subject to Rule 16b-3 | 10/11/2024 |
6 | Acquisition by Conley Sheryl L of 25000 shares of Neuronetics subject to Rule 16b-3 | 11/07/2024 |
7 | Neuronetics Inc Q3 2024 Earnings Report Preview What to Expect | 11/11/2024 |
8 | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635 | 11/12/2024 |
9 | Earnings call Neuronetics reports revenue growth amidst strategic shifts | 11/13/2024 |
10 | CANNELL CAPITAL LLC Adjusts Stake in Neuronetics Inc | 11/15/2024 |
11 | Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference | 11/20/2024 |
Check out Neuronetics Hype Analysis, Neuronetics Correlation and Neuronetics Performance. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.22) | Revenue Per Share 2.453 | Quarterly Revenue Growth (0.07) | Return On Assets (0.17) | Return On Equity (1.00) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.